Herein, leniolisib effectively blocked AKT activation in BMPR2-silenced PAECs and partially normalized cell proliferation, EndoMT and apoptosis resistance, phenotypic features associated with end stage vascular remodeling in PAH. This evidence concerns the gene AKT1 and pulmonary arterial hypertension.